Literature DB >> 18546633

Regulatory T cells: a new frontier in cancer immunotherapy.

Brian G Barnett1, Jens Rüter, Ilona Kryczek, Michael J Brumlik, Pui Joan Cheng, Benjamin J Daniel, George Coukos, Weiping Zou, Tyler J Curiel.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18546633     DOI： 10.1007/978-0-387-68969-2_20

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  14 in total

1.  Surgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma.

Authors:  Gregory T Kennedy; Brendan F Judy; Pratik Bhojnagarwala; Edmund K Moon; Zvi G Fridlender; Steven M Albelda; Sunil Singhal
Journal:  Immunol Lett       Date:  2015-05-18       Impact factor: 3.685

2.  IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo.

Authors:  Mythili Koneru; Terence J Purdon; David Spriggs; Susmith Koneru; Renier J Brentjens
Journal:  Oncoimmunology       Date:  2015-01-23       Impact factor: 8.110

3.  Adipose tissue-derived progenitor cells and cancer.

Authors:  Yan Zhang; Charles F Bellows; Mikhail G Kolonin
Journal:  World J Stem Cells       Date:  2010-10-26       Impact factor: 5.326

Review 4.  Innate immune cells in breast cancer--from villains to heroes?

Authors:  Tim Kees; Mikala Egeblad
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-07-26       Impact factor: 2.673

Review 5.  Telomerase and primary T cells: biology and immortalization for adoptive immunotherapy.

Authors:  Eugene V Barsov
Journal:  Immunotherapy       Date:  2011-03       Impact factor: 4.196

6.  The role of regulatory T cells in cancer.

Authors:  Tai-You Ha
Journal:  Immune Netw       Date:  2009-12-31       Impact factor: 6.303

Review 7.  Cell carriers for oncolytic viruses: Fed Ex for cancer therapy.

Authors:  Candice Willmon; Kevin Harrington; Timothy Kottke; Robin Prestwich; Alan Melcher; Richard Vile
Journal:  Mol Ther       Date:  2009-08-18       Impact factor: 11.454

8.  Chimeric NKG2D expressing T cells eliminate immunosuppression and activate immunity within the ovarian tumor microenvironment.

Authors:  Amorette Barber; Agnieszka Rynda; Charles L Sentman
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

Review 9.  The targeting of immunosuppressive mechanisms in hematological malignancies.

Authors:  M H Andersen
Journal:  Leukemia       Date:  2014-03-18       Impact factor: 11.528

10.  Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.

Authors:  Yi-Lan Zhang; Jiang Li; Hao-Yuan Mo; Fang Qiu; Li-Min Zheng; Chao-Nan Qian; Yi-Xin Zeng
Journal:  Mol Cancer       Date:  2010-01-10       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.